Brief: Praxis Precision Q3 EPS USD -3.36
Nov 05 (Reuters) - Praxis Precision Q3 operating expenses USD 78.359 million. Q3 net income USD -73.934 million Q3 operating income USD -78.359 million
Recent news on Praxis Precision Medicines
See all newsUS RESEARCH ROUNDUP-Arxis, Cigna, Vylor
Brief: Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Praxis Precision Medicines, Inc. reports results for the quarter ended June 30 - Earnings Summary
Praxis Precision Q2 net loss widens on higher expenses
Brief: Praxis Precision Q2 EPS USD -2.87